Gainers
• Intersect ENT, Inc. XENT shares rose 31.17% to $18.22 during Wednesday's pre-market session. The most recent rating by SVB Leerink, on Jun 29, is at Market Perform, with a price target of $14.
• Endologix, Inc. ELGX stock moved upwards by 25.12% to $0.39. According to the most recent rating by BTIG, on May 12, the current rating is at Neutral.
• VBI Vaccines, Inc. VBIV shares rose 19.94% to $4.03.
• Concert Pharmaceuticals, Inc. CNCE shares increased by 11.61% to $11.15.
• Cocrystal Pharma, Inc. COCP shares rose 11.24% to $1.78. The most recent rating by Noble Capital Markets, on Jun 16, is at Outperform, with a price target of $5.
• GenMark Diagnostics, Inc. GNMK shares increased by 10.64% to $17.25. The most recent rating by Needham, on Jul 8, is at Buy, with a price target of $19.
• Heat Biologics, Inc. HTBX shares rose 9.07% to $0.97.
• BioCryst Pharmaceuticals, Inc. BCRX shares moved upwards by 9.05% to $5.90. According to the most recent rating by BTIG, on Jun 17, the current rating is at Neutral.
• CHF Solutions, Inc. CHFS shares increased by 8.87% to $0.65.
• InflaRx, Inc. IFRX stock moved upwards by 8.20% to $5.54. The most recent rating by BTIG, on Jun 17, is at Buy, with a price target of $12.
Losers
• VIVUS, Inc. VVUS shares declined 35.61% to $0.52 during Wednesday's pre-market session.
• Hepion Pharmaceuticals, Inc. HEPA shares declined 10.68% to $3.68.
• 89bio, Inc. ETNB shares decreased by 6.96% to $30.75. The most recent rating by Chardan Capital, on Jul 7, is at Buy, with a price target of $58.
• Acasti Pharma, Inc. ACST stock decreased by 5.28% to $0.68. The most recent rating by B. Riley FBR, on Jul 6, is at Buy, with a price target of $2.
• AEterna Zentaris, Inc. AEZS stock declined 5.19% to $0.49.
• HealthEquity, Inc. HQY stock declined 4.91% to $55.25. The most recent rating by Cantor Fitzgerald, on Jun 3, is at Overweight, with a price target of $70.
• Viveve Medical, Inc. VIVE shares decreased by 4.84% to $0.61.
• China SXT Pharmaceuticals, Inc. SXTC stock decreased by 4.65% to $0.54.
• Diffusion Pharmaceuticals, Inc. DFFN stock fell 4.42% to $0.88.
• Aclaris Therapeutics, Inc. ACRS stock fell 3.96% to $1.70.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.